Archer-Daniels-Midland Co quarterly report, Q1 FY2024

Archer-Daniels-Midland Company: Q1 2024 Form 10-Q Summary

Business context and reporting period

ADM is a global agricultural supply-chain manager, commodity processor, and human and animal nutrition provider operating in more than 190 countries. Reported results cover the three months ended March 31, 2024, compared with the three months ended March 31, 2023. Reportable segments are Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition, with remaining activities classified as Other Business.

Key financial metrics

MetricQ1 2024Q1 2023Change
Revenue$21.847 billion$24.072 billionDown $2.225 billion
Gross profit$1.659 billion$2.080 billionDown 20%
Gross margin7.6%8.6%Down approximately 1.0 percentage point
Net earnings attributable to controlling interests$729 million$1.170 billionDown 38%
Diluted EPS$1.42$2.12Down $0.70
Adjusted diluted EPS$1.46$2.09Down $0.63
Operating cash flow$700 million$(1.610) billionImproved $2.310 billion
Adjusted EBITDA$1.298 billion$1.762 billionDown $464 million

Segment operating profit was $1.311 billion, down from $1.719 billion. Ag Services and Oilseeds contributed $864 million, Carbohydrate Solutions $248 million, Nutrition $84 million, and Other Business $121 million. Processed volumes increased to 13.794 million metric tons from 13.021 million, primarily reflecting higher oilseed crush volumes.

At March 31, 2024, cash and cash equivalents were $830 million, total debt was approximately $9.980 billion, and shareholders’ equity was $23.232 billion. Total credit lines were $12.8 billion, with $8.8 billion unused. Total available liquidity was $9.6 billion. The current ratio was 1.5 to 1, long-term debt to total capital was 26%, and net debt to capital was 28%.

Capital expenditures were $328 million. ADM spent $1.327 billion on share repurchases and paid $257 million in dividends. The quarterly dividend was $0.50 per share, compared with $0.45 in the prior-year quarter.

Material changes versus the prior comparable period

  • Revenue declined 9%, driven primarily by lower commodity selling prices, partially offset by higher sales volumes.
  • Ag Services and Oilseeds operating profit fell $347 million, reflecting normalized trade flows, lower global trade and risk-management results, weaker crush margins, and pressure on refined-products margins.
  • Carbohydrate Solutions operating profit declined $31 million. Starches and Sweeteners weakened, while Vantage Corn Processors improved but remained loss-making at the segment level.
  • Nutrition operating profit decreased $54 million. Human Nutrition was affected by unplanned downtime, a normalizing texturants market, inflation, and softer demand; Animal Nutrition improved on cost optimization and lower input costs.
  • Corporate expense increased to $426 million from $322 million, primarily because of higher legal and professional fees, technology spending, incentive compensation, financing costs, and $12 million of restructuring charges.
  • The effective tax rate increased to 18.8% from 16.1%, mainly due to geographic earnings mix and discrete tax items.
  • ADM acquired Revela Foods, FDL, and PT Trouw Nutrition Indonesia for aggregate cash consideration of $924 million, or $915 million net of cash acquired. The acquisitions added capabilities in human and animal nutrition; post-acquisition results were immaterial to the quarter.

Guidance, outlook, risks, contingencies, and unusual items

Management expects approximately $1.3 billion of 2024 capital expenditures, approximately $1.0 billion of dividends, and up to $2.3 billion of share repurchases, subject to strategic capital needs, operating cash flow, and working-capital requirements. No full-year earnings guidance is provided in the filing.

Management described agricultural-market conditions as more normalized after two favorable years. Principal near-term pressures include South American farmer-selling patterns, lower export demand, commodity-price volatility, excess ethanol inventories, used-cooking-oil imports, softer food and beverage demand, weak amino-acid markets, and challenged global feed demand. Weather, crop conditions, energy costs, trade policies, geopolitical developments, foreign exchange, and global economic conditions remain material risks.

ADM’s disclosure controls and internal control over financial reporting were not effective as of March 31, 2024 because of a material weakness involving controls over the measurement and reporting of certain intersegment sales. The company is implementing enhanced accounting policies, pricing guidelines, controls, documentation, and training, but has not yet concluded that the weakness is remediated.

The SEC and Department of Justice are investigating intersegment sales involving Nutrition, Ag Services and Oilseeds, and Carbohydrate Solutions. ADM is cooperating and cannot predict the outcome. Related securities and derivative lawsuits have also been filed. The filing also describes commodity class-action litigation involving alleged ethanol-market manipulation; ADM denies liability and believes the outcome will not materially affect its financial condition, results of operations, or cash flows, although the ultimate outcome remains uncertain.

Other notable items include a $18 million asset impairment, exit, and restructuring charge; an $18 million revaluation loss related to an alternative-protein and precision-fermentation investment, partially offset by a $2 million upward adjustment; and a $1.0 billion accelerated share repurchase agreement. The ASR was finally settled on April 15, 2024 with delivery of 7.3 million additional shares.

Important facts for investors to verify

  • Progress and testing results for remediation of the material weakness in intersegment-sales controls.
  • Developments, potential financial exposure, and disclosure consequences of the SEC and DOJ investigations and related shareholder litigation.
  • Whether normalized agricultural margins, ethanol oversupply, refined-products pressure, and softer Nutrition demand persist through 2024.
  • ADM’s ability to fund planned acquisitions, capital expenditures, dividends, and share repurchases while net debt to capital remains elevated versus year-end 2023.
  • The renewal or replacement of the $1.9 billion accounts-receivable securitization program scheduled to terminate May 17, 2024, unless extended.
  • Segment performance after the acquisitions of Revela, FDL, and PT Trouw Nutrition Indonesia and the final purchase-price allocation adjustments.